Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma

It has been shown previously that gene expression profiling signature (a set of dysregulated genes) can be used for molecular classification, diagnosis, and prognosis of several types of cancers. In This study the hypothesise that resistant tumor may be due to genetic mutations and/or other alternative pathways that could be …

platelet count
prothrombin
cancer
vascular invasion
coumadin
  • 16 views
  • 23 Jan, 2021
  • 1 location
Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma

The study evaluates the protective effect of low-dose aspirin use as adjuvant therapy on locally advanced renal cell carcinoma in users and non-users of aspirin in Renji Hospital, Shanghai

  • 2 views
  • 22 Jan, 2021
  • 1 location
Observational Real-life Study of Cabozantinib in Advanced Renal Cell Carcinoma (RCC)

The purpose of this study is to describe the real-life use of Cabometyx in Belgium and the Netherlands in patients with advanced or metastatic Renal Cell Carcinoma (1st, 2nd and later lines of treatment)

  • 2 views
  • 29 Jan, 2021
  • 23 locations
Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

The objective of this study is to monitor the usage of INLYTA in real practice within label, including the adverse events associated with INLYTA.

  • 7 views
  • 14 Feb, 2021
  • 1 location
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

The objective of this study is to understand the utilization of cabozantinib in subjects with advanced renal cell carcinoma (RCC) following prior VEGF-targeted therapy in real life settings in

cabozantinib
advanced renal cell carcinoma
growth factor
carcinoma
vegf
  • 148 views
  • 03 Mar, 2021
  • 142 locations
Registry Platform Renal Cell Carcinoma

characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced Renal Cell Carcinoma in Germany

advanced renal cell carcinoma
carcinoma
  • 46 views
  • 24 Jan, 2021
  • 1 location
Registry For Temsirolimus Sunitinib And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC) Mantle Cell Lymphoma (MCL) And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

The purpose of this registry is to obtain a general view as regards efficacy, tolerability and safety issues of the Torisel, Sutent, and/or Inlyta therapies in patients with advanced renal cell

temsirolimus
refractory mantle cell lymphoma
  • 46 views
  • 25 Jan, 2021
  • 117 locations
AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points 5 Non-metastatic ccRCC

AUR87A is an observational prospective multicenter diagnostics test cohort study for detection of renal cell carcinoma recurrence as determined by the reference standard, which is imaging using computed tomography (CT) of the chest and abdomen at defined intervals after primary surgery.

ct scan
cancer
carcinoma
primary tumor
metastasis
  • 1 views
  • 26 Jan, 2021
  • 16 locations
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective Non-interventional Study

This is a non-interventional study to retrospectively evaluate the safety and to describe the effectiveness of cabozantinib after immunoncologic treatment with nivolumab or nivolumab plus ipilimumab in routine clinical practice. It consists of a retrospective chart review of patients who have already completed treatment with cabozantinib after nivolumab or nivolumab …

  • 1 views
  • 17 Feb, 2021
  • 3 locations
Spanish Real-World Evidence Cabozantinib

temporary Authorization for special use to Cabometyx 20/40/60 mg within a Managed Access Program (MAP) for the treatment of advanced RCC in adults following prior VEGF-targeted therapy (Vascular

nivolumab
cabozantinib
advanced renal cell carcinoma
growth factor
carcinoma
  • 0 views
  • 25 Jan, 2021
  • 29 locations